Search
  1. Home
  2. Southern Africa
  3. South Africa

Another TAC/Rath court case looms

    JOHANNESBURG

    The South African AIDS lobby group, Treatment Action Campaign (TAC), will be back in court in three to four months' time for another round with German vitamin entrepreneur Matthias Rath.

    This time the ministry of health and the Medicines Control Council (MCC) are also being dragged into the fight for their alleged lack of action against Rath, who has claimed his vitamins were more effective than antiretroviral drugs in treating HIV/AIDS.

    Rath has been able to continue selling his vitamins as anti-AIDS medication, despite a year-long investigation by the MCC.

    TAC spokesman Nathan Geffen said he believed the MCC had acted negligently. "From everything I have seen and heard ... no proper investigation has taken place into the activities of Matthias Rath, despite complaints being lodged by ourselves and other organisations and individuals," he told the South African Broadcasting Corporation.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join